Review article
Microbial/host interactions in health and disease: Who controls the cytokine network?

https://doi.org/10.1016/0162-3109(96)00144-0Get rights and content

Abstract

The interacting cellular and molecular systems which we classify as immunity and inflammation evolved to protect the organism from exogenous parasites including viruses and bacteria. Cytokines play a pivotal, but paradoxical, role both in immunity and inflammation. These local peptide hormone-like molecules form a major arm of the organisms' defenses against infectious microorganisms but they are also implicated as potent mediators of the pathology of infectious diseases. The apparently lethal effects of interleukin-1 and tumor necrosis factor in experimental septic shock testify to the latter. In the current paradigm, cytokine induction, as a protective or pathological mechanism, is a direct response to the presence of infectious microorganisms. Evidence is now accumulating that cytokines play a much more complex role in the interplay between exogenous microorganisms and the host. For example, it has been established that viruses have evolved pro-active methods of subverting the cytokine network by producing: (i) soluble cytokine receptors which bind and inactivate cytokines, (ii) immunomodulatory cytokine homologues, and (iii) ICE inhibitors. The possibility exists that the major role of these ‘viral cytokines’ is to neutralize certain host responses. Recent cytokine transgenic knockouts demonstrate that the normal benign response to commensal gut microflora becomes a lethal inflammatory state in the absence of the cytokines interleukin 2 or interleukin 10. The human body contains an enormous number of microorganisms which constitute the normal microflora. It is estimated that the average human contains 1013 eukaryotic cells but 1014 bacteria. We propose that the ability of the multicellular organism to live harmoniously with its commensal microflora must depend on mutual signalling involving eukaryotic cytokines and prokaryotic cytokine-like molecules. Such interactive signalling sets up non-inflammatory cytokine networks in tissues which form the background on which responses to infectious microorganisms must be built and related. The capacity of bacteria to induce cytokine synthesis was believed to be due to a small number of components, such as lipopolysaccharide (LPS), which is only active as a complex with host factors (lipopolysaccharide binding protein and CD14). However, it is now clear that bacteria contain and produce a large number of diverse molecules which can selectively induce the synthesis of both pro-inflammatory and immunomodulatory/anti-inflammatory cytokines. Many toxins are potent inducers of cytokine release or synthesis and some can inhibit LPS-induced cell activation. We have introduced the term bacteriokine to describe these bacterial cytokine inducers. The question that has to be addressed therefore is — who controls the cytokine network (eukaryotic or prokaryotic cells) and how is it controlled? It is proposed that an understanding of this question will bring with it an understanding of how to control the pathological inflammatory response and may allow the development of truly effective anti-inflammatory agents.

References (126)

  • T.L. Kielian et al.

    CD14 and other recognition molecules for lipopolysaccharide: A review

    Immunopharmacology

    (1995)
  • T.K. Komiyama et al.

    Inhibition of interleukin-1 β converting enzyme by the cowpox virus serpin CrmA

    J. Biol. Chem.

    (1994)
  • P. Marrack et al.

    Subversion of the immune system by pathogens

    Cell

    (1994)
  • D.C. Morrison et al.

    Fractions of lipopolysaccharide from Escherichia coli 0111:B4 prepared by two extraction procedures

    J. Biol. Chem.

    (1975)
  • M. Otterlei et al.

    Characterization of binding and TNFa-inducing ability of chitosans on monocytes: The involvement of CD14

    Vaccine

    (1994)
  • J. Pugin et al.

    CD14 is a pattern recognition receptor

    Immunity

    (1994)
  • C.A. Ray et al.

    Viral inhibition of inflammation: Cowpox virus encodes an inhibitor of the interleukin-1 β converting enzyme

    Cell

    (1992)
  • B. Sadlack et al.

    Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene

    Cell

    (1993)
  • E. Atkins

    Fever: Historical aspects

  • I.B. Autenrieth et al.

    In vivo neutralization of tumor necrosis factor-alpha and interferon-gamma abrogates resistance to Yersinia enterocolitica infection in mice

    Med. Microbiol. Immunol.

    (1992)
  • H.U. Beuscher et al.

    Bacterial evasion of host immune defence: Yersinia enterocolitica encodes a suppressor factor for tumor necrosis factor alpha expression

    Infect. Immun.

    (1995)
  • S. Bhakdi et al.

    Release of interleukin-1 β associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes

    Infect. Immun.

    (1989)
  • S. Bhakdi et al.

    Effects of Escherichia coli hemolysin on human monocytes: Cytocidal action and stimulation of interleukin-1 release

    J. Clin. Invest.

    (1990)
  • R.C. Bone

    Gram-negative sepsis: A dilemma of modern medicine

    Clin. Microbiol. Rev.

    (1993)
  • R.C. Bone

    Gram positive organisms and sepsis

    Arch. Intern. Med.

    (1994)
  • B.E. Barton et al.

    Interleukins 6 and 11 protect mice from mortality in a staphylococcal enterotoxin-induced toxic shock model

    Infect. Immun.

    (1996)
  • A.E. Chernoff et al.

    A randomized, controlled trial of IL-10 in humans

    J. Immunol.

    (1995)
  • T.P. Chua et al.

    Inflammatory responses and the generation of chemoattractant activity in cowpox virus-infected tissues

    Immunology

    (1990)
  • D.N. Cook et al.

    Requirement for MIP-1 α for an inflammatory response to viral infection

    Science

    (1995)
  • G.M. Cooper
  • K.E. Dahl et al.

    Selective induction of transforming growth factor β in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis

    Infect. Immun.

    (1996)
  • R.L. Delude et al.

    CD14 enhances cellular responses to endotoxin without imparting ligandspecific recognition

  • M. Denis

    Growth of Mycobacterium avium in human monocytes: Identification of cytokines which reduce and enhance intracellular microbial growth

    Eur. J. Immunol.

    (1991)
  • M. Denis et al.

    Recombinant tumour necrosis factor-alpha decreases whereas recombinant interleukin-6 increases growth of a virulent strain of Mycobacterium avium in human macrophages

    Immunology

    (1990)
  • M. Denis et al.

    Interleukin-2 and granulocyte-macrophage colony-stimulating factor stimulate growth of a virulent strain of Escherichia coli

    Infect. Immun.

    (1991)
  • C.A. Dinarello

    Was the original endogenous pyrogen interleukin-1?

  • T. Espevik et al.

    The involvement of CD14 in stimulation of cytokine production by uronic acid polymers

    Eur. J. Immunol.

    (1993)
  • K.R. Feingold et al.

    Role for circulating lipoproteins in protection from endotoxin toxicity

    Infect. Immun.

    (1995)
  • M.J. Fenton et al.

    Minireview: Immunopathology of tuberculosis: Roles of macrophages and monocytes

    Infect. Immun.

    (1996)
  • W.A. Flegel et al.

    Cytokine response by human monocytes to Clostridium difficle toxin A and toxin B

    Infect. Immun.

    (1991)
  • J. Fletcher et al.

    Interactions between periodontopathic bacteria and cytokines

    J. Periodontol.

    (1996)
  • T.N. Frederickson et al.

    Acute inflammatory response to cowpox virus infection of the chorioallantoic membrane of the chick embryo

    Virology

    (1992)
  • E.A. Frey et al.

    Soluble CD14 participates in the response of cells to lipopolysaccharide

    J. Exp. Med.

    (1992)
  • R. Gianani et al.

    Viruses, cytokines, antigens, and autoimmunity

  • L.R. Gooding

    Viral proteins that counteract host immune defenses

    Cell

    (1992)
  • L.R. Gooding

    Regulation of TNF-mediated cell death and inflammation by human adenoviruses

    Infect. Agents Dis.

    (1994)
  • U. Grunwald et al.

    An enzyme linked immunoassay for the quantification of solubilized CD14 in biological fluids

    J. Immunol. Methods

    (1994)
  • A. Haziot et al.

    The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage

    J. Immunol.

    (1988)
  • A. Haziot et al.

    CD14-deficient mice are exquisitely sensitive to the effects of LPS

  • B. Henderson et al.

    Modulins: A new class of cytokine-inducing, pro-inflammatory bacterial virulence factor

    Inflamm. Res.

    (1995)
  • Cited by (65)

    • The effect of zirconia and titanium surfaces on biofilm formation and on host-derived immunological parameters

      2021, International Journal of Oral and Maxillofacial Surgery
      Citation Excerpt :

      Cytokines are a group of small soluble proteins that alter cell properties by means such as proliferation, differentiation, and regeneration on a local or systemic level75. Basically, these can be classified into (1) proinflammatory cytokines (interleukin (IL)-1, IL-6, IL-8, interferon gamma (IFN-γ), tumour necrosis factor alpha (TNF-α)), as found in excessive amounts in periodontally inflamed tissues76–78, and (2) anti-inflammatory cytokines (transforming growth factor beta (TGF-β), IL-10)79. The relationship between these groups determines the extent of inflammation.

    • Acute phase proteins, proinflammatory cytokines and oxidative stress biomarkers in sheep, goats and she-camels with Coxiella burnetii infection-induced abortion

      2019, Comparative Immunology, Microbiology and Infectious Diseases
      Citation Excerpt :

      Inflammatory cytokines such as tumor necrosis factor-alpha can exert harmful effects in the placenta and tend to be present at low concentrations; however, the other regulatory cytokines such as interleukin (IL)-10 is beneficial and tend to predominate [11]. This implies that bacterial challenges that focused on placenta and that produce inflammatory responses may lead to abortion by giving rise to a damaging combination of cytokines that causes damage but does not control the disease [11–13]. Moreover, cytokines are considered as effective motivators for acute phase protein (APP) synthesis [14].

    • Role for tumor necrosis factor alpha (TNF-α) and interleukin 1-beta (IL-1β) determination in seminal plasma during infertility investigation

      2007, Fertility and Sterility
      Citation Excerpt :

      It may cause intravascular thrombosis, effects myocardial contractility and vascular smooth muscle activity, and may cause severe metabolic disturbances such as hypoglycemia. Hepatocyte-derived plasma proteins induced by TNF and other cytokines of innate immunity contribute to the acute-phase response to inflammatory stimuli (1–8). The synthesis of IL-1 can also be induced by endotoxins, viruses, mitogens, and antigens.

    • Mucosal microbiota

      2005, Mucosal Immunology, Two-Volume Set
    View all citing articles on Scopus
    View full text